Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
Graphic Arrow Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
Graphic Arrow Attach to Form 990.
Graphic Arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2020
Open to Public Inspection
Name of the organization
HACKENSACK MERIDIAN HEALTH INC-SUBORDINATES
 
Employer identification number

01-0649794
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....
1b
Yes
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....
2
Yes
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2020

Schedule J (Form 990) 2020
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits
(E) Total of columns
(B)(i)-(D)
(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation
(ii) Bonus & incentive
compensation
(iii) Other reportable compensation
1Robert C Garrett FACHE
CEO/Trustee
(i)

(ii)
2,159,815
-------------
0
2,050,561
-------------
0
2,322,430
-------------
0
313,909
-------------
0
25,002
-------------
0
6,871,717
-------------
0
1,224,200
-------------
0
2Robert L Glenning
Pres, Fin & IT Svcs Div, CFO
(i)

(ii)
1,273,594
-------------
0
626,510
-------------
0
1,098,194
-------------
0
14,250
-------------
0
29,590
-------------
0
3,042,138
-------------
0
350,554
-------------
0
3Mark Stauder
Chairperson/COO
(i)

(ii)
1,448,581
-------------
0
651,420
-------------
0
493,598
-------------
0
14,250
-------------
0
22,574
-------------
0
2,630,423
-------------
0
0
-------------
0
4Ihor Sawczuk MD
Trustee/Reg. Pres, Hospitals
(i)

(ii)
1,561,167
-------------
0
512,385
-------------
0
282,704
-------------
0
68,700
-------------
0
22,174
-------------
0
2,447,130
-------------
0
0
-------------
0
5Joseph M Lemaire
Pres., Diversified Ventures
(i)

(ii)
1,162,797
-------------
0
486,468
-------------
0
602,411
-------------
0
14,250
-------------
0
23,294
-------------
0
2,289,220
-------------
0
164,408
-------------
0
6Patrick Young
Pres, Population Health
(i)

(ii)
919,146
-------------
0
564,417
-------------
0
618,260
-------------
0
351,200
-------------
0
32,419
-------------
0
2,485,442
-------------
0
245,137
-------------
0
7Nancy Corcoran-Davidoff
Vice Chair/EVP, Chf Exp&HR Off
(i)

(ii)
793,520
-------------
0
238,351
-------------
0
1,046,517
-------------
0
71,103
-------------
0
21,974
-------------
0
2,171,465
-------------
0
273,842
-------------
0
8Audrey C Murphy ESQ MSN RN
EVP, Chf Legal Officer, Oper
(i)

(ii)
792,468
-------------
0
302,100
-------------
0
725,028
-------------
0
173,315
-------------
0
30,202
-------------
0
2,023,113
-------------
0
301,781
-------------
0
9James Blazar
EVP, Chief Strategy Officer
(i)

(ii)
889,414
-------------
0
342,586
-------------
0
591,896
-------------
0
14,250
-------------
0
22,174
-------------
0
1,860,320
-------------
0
131,304
-------------
0
10Kenneth N Sable MD
Reg Pres, Hospitals
(i)

(ii)
1,035,646
-------------
0
401,011
-------------
0
204,758
-------------
0
168,750
-------------
0
37,419
-------------
0
1,847,584
-------------
0
122,955
-------------
0
11Ann B Gavzy Esq
EVP, Chief Legal Off, T&C Svcs
(i)

(ii)
791,835
-------------
0
302,100
-------------
0
673,087
-------------
0
22,800
-------------
0
25,194
-------------
0
1,815,016
-------------
0
103,241
-------------
0
12Catherine A Ainora
EVP, Chief Integration Officer
(i)

(ii)
761,023
-------------
0
284,833
-------------
0
535,689
-------------
0
14,250
-------------
0
12,432
-------------
0
1,608,227
-------------
0
204,469
-------------
0
13Joseph Parrillo MD
Chairman, HVH
(i)

(ii)
1,293,412
-------------
0
100,375
-------------
0
106,329
-------------
0
14,250
-------------
0
20,434
-------------
0
1,534,800
-------------
0
0
-------------
0
14Mark D Sparta MD
President, CHE, HUMC, EVP Pop
(i)

(ii)
867,734
-------------
0
279,234
-------------
0
204,336
-------------
0
96,665
-------------
0
31,469
-------------
0
1,479,438
-------------
0
41,808
-------------
0
15Timothy J Hogan
President, CTS
(i)

(ii)
829,435
-------------
0
307,824
-------------
0
332,626
-------------
0
22,800
-------------
0
4,865
-------------
0
1,497,550
-------------
0
0
-------------
0
16Raymond F Fredericks
Reg Pres,Hosp. (Termed 6/2019)
(i)

(ii)
0
-------------
0
147,701
-------------
0
1,074,598
-------------
0
0
-------------
0
0
-------------
0
1,222,299
-------------
0
0
-------------
0
17Jeffrey R Boscamp
SVP, SCH OF MED DVLPMNT/CO-CAO
(i)

(ii)
688,247
-------------
0
216,472
-------------
0
146,038
-------------
0
71,373
-------------
0
2,650
-------------
0
1,124,780
-------------
0
0
-------------
0
18Manuel Alvarez MD
Staff Physician
(i)

(ii)
527,408
-------------
369,750
35,759
-------------
0
27,823
-------------
0
69,223
-------------
0
28,051
-------------
0
688,264
-------------
369,750
4,453
-------------
0
19Todd Way
REG PRESIDENT, HOSPITALS
(i)

(ii)
720,375
-------------
0
150,000
-------------
0
50,376
-------------
0
120,813
-------------
0
27,269
-------------
0
1,068,833
-------------
0
0
-------------
0
20Joseph E Stampe
Regional Pres, Foundations
(i)

(ii)
459,837
-------------
0
244,991
-------------
0
156,096
-------------
0
49,249
-------------
0
32,419
-------------
0
942,592
-------------
0
62,385
-------------
0
21Paul Chung MD
Trustee/Physician, SOMC
(i)

(ii)
551,243
-------------
0
20,000
-------------
0
251,746
-------------
0
14,250
-------------
0
28,647
-------------
0
865,886
-------------
0
0
-------------
0
22Gusta A Pritchett
SVP, Revenue Cycle Operations
(i)

(ii)
515,868
-------------
0
139,487
-------------
0
151,942
-------------
0
5,700
-------------
0
12,432
-------------
0
825,429
-------------
0
0
-------------
0
23Richard C Smith
SVP, Finance (TERMED 12/2020)
(i)

(ii)
559,017
-------------
0
154,077
-------------
0
41,374
-------------
0
9,975
-------------
0
21,595
-------------
0
786,038
-------------
0
0
-------------
0
24Pranaychandra Vaidya MD
Trustee/Chief, Cath Lab
(i)

(ii)
686,354
-------------
0
32,633
-------------
0
35,645
-------------
0
5,700
-------------
0
22,079
-------------
0
782,411
-------------
0
0
-------------
0
25John K Lloyd FACHE
Former Co-CEO (Termed 12/2018)
(i)

(ii)
0
-------------
0
0
-------------
0
806,128
-------------
0
0
-------------
0
0
-------------
0
806,128
-------------
0
0
-------------
0
26Helen A Cunning
Regional Pres, Foundations
(i)

(ii)
387,368
-------------
0
191,918
-------------
0
82,093
-------------
0
72,070
-------------
0
22,174
-------------
0
755,623
-------------
0
28,030
-------------
0
27William Oser MD
Trustee/CMO, JFKMC
(i)

(ii)
584,038
-------------
0
81,268
-------------
0
29,374
-------------
0
14,250
-------------
0
30,430
-------------
0
739,360
-------------
0
0
-------------
0
28Donna Snider CFA
SVP, Chief Investment Officer
(i)

(ii)
564,734
-------------
0
150,000
-------------
0
28,453
-------------
0
75,621
-------------
0
25,054
-------------
0
843,862
-------------
0
0
-------------
0
29Andrew L Pecora MD
Pres, Phys Div(Termed 5/2019)
(i)

(ii)
0
-------------
0
166,188
-------------
0
546,775
-------------
0
0
-------------
0
0
-------------
0
712,963
-------------
0
445,732
-------------
0
30Donald Parker
Trustee/Pres, Carrier Clinic
(i)

(ii)
399,415
-------------
0
156,901
-------------
 
47,903
-------------
 
14,250
-------------
0
23,644
-------------
0
642,113
-------------
0
0
-------------
0
31Thomas Salazer MD
Trustee/chief, nephrology
(i)

(ii)
114,232
-------------
473,424
0
-------------
0
0
-------------
5,969
0
-------------
4,275
0
-------------
14,034
114,232
-------------
497,702
0
-------------
0
32Harpreet Pall MD
Trustee/CHAIRMAN, GASTRO
(i)

(ii)
514,640
-------------
0
16,961
-------------
0
44,516
-------------
0
14,250
-------------
0
13,056
-------------
0
603,423
-------------
0
0
-------------
0
33Richard M Neibart MD
Trustee/Srvc Line Medical Dir.
(i)

(ii)
569,569
-------------
0
0
-------------
0
15,000
-------------
0
14,250
-------------
0
0
-------------
0
598,819
-------------
0
0
-------------
0
34Amie Thornton
Trustee/CHF HOSP EXEC, JFK
(i)

(ii)
435,810
-------------
0
72,408
-------------
0
6,874
-------------
0
56,217
-------------
0
2,615
-------------
0
573,924
-------------
0
0
-------------
0
35John D Royall MD
Trustee/Physician, SOMC
(i)

(ii)
427,128
-------------
0
20,000
-------------
0
10,454
-------------
0
14,250
-------------
0
1,870
-------------
0
473,702
-------------
0
0
-------------
0
36Aida Capo MD
Trustee/Medical Director, PMA
(i)

(ii)
36,425
-------------
306,226
 
-------------
21,860
 
-------------
2,609
 
-------------
12,305
 
-------------
27,244
36,425
-------------
370,244
0
-------------
0
37Joyce Hendricks
Chief Devel Officer
(i)

(ii)
269,997
-------------
0
32,000
-------------
0
63,609
-------------
0
13,686
-------------
0
2,961
-------------
0
382,253
-------------
0
0
-------------
0
38Sarah L Timmapuri MD
Trustee/Physician, HUMC
(i)

(ii)
236,051
-------------
11,242
9,636
-------------
0
21,753
-------------
0
13,421
-------------
0
20,300
-------------
0
301,161
-------------
11,242
0
-------------
0
39Surender M Grover MD
Secretary/Chairman, MD Dept
(i)

(ii)
269,419
-------------
0
0
-------------
0
3,582
-------------
0
13,500
-------------
0
1,958
-------------
0
288,459
-------------
0
0
-------------
0
40Suri Ponamgi MD
Trustee/Chairman, Surgery, PMA
(i)

(ii)
194,981
-------------
0
0
-------------
0
15,025
-------------
0
10,776
-------------
0
17,476
-------------
0
238,258
-------------
0
0
-------------
0
41Mark D Schlesinger MD
Trustee/Chair, Anesthesiology
(i)

(ii)
159,639
-------------
0
12,045
-------------
0
2,002
-------------
0
6,473
-------------
0
9,032
-------------
0
189,191
-------------
0
0
-------------
0
42AdrIan M Pristas MD
Trustee/Corp. Medical Director
(i)

(ii)
152,453
-------------
0
0
-------------
0
1,851
-------------
0
6,375
-------------
0
16,755
-------------
0
177,434
-------------
0
0
-------------
0
43Linda Hill
Ex Dir, Fndtn (Termed 11/2020)
(i)

(ii)
152,249
-------------
0
0
-------------
0
1,470
-------------
0
5,486
-------------
0
14,659
-------------
0
173,864
-------------
0
0
-------------
0
44DANIEL VARGA MD
CHIEF PHYSICIAN EXECUTIVE
(i)

(ii)
850,513
-------------
0
100,000
-------------
0
93,043
-------------
0
14,250
-------------
0
28,421
-------------
0
1,086,227
-------------
0
0
-------------
0
Schedule J (Form 990) 2020

Schedule J (Form 990) 2020
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
SCHEDULE J, PART I; QUESTION 1A Please refer to our response to Schedule J, Part I, Question 4B
SCHEDULE J, PART I; QUESTION 3 PLEASE REFER TO OUR RESPONSE TO CORE FORM, PART VI, QUESTIONS 15A & 15B INCLUDED IN SCHEDULE O.
SCHEDULE J; PART I; QUESTION 4A THE FOLLOWING INDIVIDUAL RECEIVED SEVERANCE PAYMENTS DURING THE YEAR ENDED DECEMBER 31, 2020. THE FOLLOWING AMOUNT WAS INCLUDED IN THE INDIVIDUAL'S 2020 W-2 AND IN COLUMN (B) OF SCHEDULE J: RAYMOND F. FREDERICKS, $1,077,404.
SCHEDULE J; PART I; QUESTION 4B THE AMOUNT REFLECTED IN COLUMN B(III) FOR THE FOLLOWING INDIVIDUALS INCLUDES PARTICIPATION IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ("SERP") AS THE AMOUNTS WERE NO LONGER SUBJECT TO A SUBSTANTIAL RISK OF COMPLETE FORFEITURE. THE AMOUNTS OUTLINED HEREIN WERE INCLUDED IN EACH INDIVIDUAL'S 2020 FORM W-2 AS TAXABLE WAGES: ROBERT C. GARRETT, FACHE, $715,088; NANCY CORCORAN-DAVIDOFF, $601,132; ROBERT L. GLENNING, $337,931; TIMOTHY J. HOGAN, $299,264; ANN B. GAVZY, ESQ., $275,280; AUDREY C. MURPHY, ESQ., MSN, RN, $244,452; MARK STAUDER, $210,000; IHOR S. SAWCZUK, M.D., $200,896; KENNETH N. SABLE, M.D., $165,598; PATRICK YOUNG, $157,275; JAMES BLAZAR, $131,990; JOSEPH E. STAMPE, $116,645; CATHERINE AINORA, $113,095; ANDREW L. PECORA, M.D., $110,781; MARK D. SPARTA, M.D., $106,475; JOSEPH E. PARRILLO, M.D., $87,500; JEFFREY BOSCAMP, $81,784; DANIEL VARGA, MD, $71,250; GUSTA A. PRITCHETT, $62,337; JOYCE HENDRICKS, $43,875; HELEN A. CUNNING, $36,157; AND MANUEL ALVAREZ, M.D., $10,075. The amounts listed in column B(iii) for the following individuals includes a payment of benefits under a long-term incentive plan. THE AMOUNTS OUTLINED HEREIN WERE INCLUDED IN EACH INDIVIDUAL'S 2020 FORM W-2 AS TAXABLE WAGES: Robert C. Garrett, FACHE; $1,309,744; Robert L. Glenning, $566,555; Joseph M. Lemaire, $520,603; Andrew L. Pecora,, MD, $435,994; Patrick Young, $407,896; James Blazar, $383,519; Ann B. Gavzy, Esq., $342,607; AUDREY C. MURPHY, ESQ., MSN, RN, $342,607; Catherine Ainora, $333,134; Nancy Corcoran-Davidoff, $310,728; Mark Stauder, $224,000. The amounts listed in column B(iii) for John K. Lloyd, FACHE includes a payment of benefits under a long-term incentive plan in the amount $760,312 as well as an annuity payout of $45,816 from the nonqualified supplemental executive retirement plan provided by Jersey Shore Medical Center to Mr. Lloyd for his past services as CEO, and which is paid in annuity form. HUMC SERP is a Defined Benefit (DB) executive retirement benefit plan under which benefits have been frozen since 2011. FICA taxes on a participant's DB SERP benefits are not due until the full and final benefit becomes "reasonably ascertainable", which happens when the participant terminates employment. IRS regulations permit DB SERP plan sponsors to pay FICA taxes on the accrued benefits before participants terminate employment ("Early Inclusion") even though the benefit is not yet finally calculated and paid to the participant. This can be done as many times as the plan sponsor wishes before the actual termination date. Per the "non-duplication rule", once FICA tax is paid on the value of a benefit, no further FICA tax is owed on the same benefit value. HMH complied with this special rule by paying applicable FICA tax on the accrued benefits in 2020. The individuals listed below had amounts reported on their W-2s in box 3 and box 5 (solely for the purpose of paying FICA tax under the early inclusion rule), but the individuals did not actually receive the amounts. The taxable amounts had already been included in box 1 of their W-2s in 2010 and prior years. As a result, the amounts were not included in the compensation amounts reported in Part VII and in Schedule J again for 2020. The excess of the amounts reported in box 3 and box 5 of the 2020 Forms W-2 over the amounts reported in box 1 of the 2020 Form W-2 are as follows for the individuals reported in Part VII: ROBERT C. GARRETT, FACHE, $4,520,514; JEFFREY BOSCAMP, $1,804,507; IHOR S. SAWCZUK, $1,258,660; NANCY CORCORAN-DAVIDOFF, $1,191,920; AUDREY C. MURPHY, ESQ., MSN, RN, $797,963; MANUEL ALVAREZ, M.D., $755,468; ANDREW L. PECORA, M.D., $672,252; GUSTA A. PRITCHETT, $550,508; ROBERT L. GLENNING, $449,592; MARK D. SPARTA, M.D., $18,274. The highest compensated employees listed in Part VII were determined separately using both box 1 and box 5, with all individuals who are highest compensated under either method being listed. Upon retirement of a participant, and as required by the DB SERP plan, HMH provides a full tax gross-up on the benefits earned by the participant. HMH provides reimbursement of the tax so that the benefit is provided without cost to the individual. THE DEFERRED COMPENSATION AMOUNT REFLECTED IN COLUMN (C) FOR THE FOLLOWING INDIVIDUALS INCLUDES A RETENTION BONUS WHICH IS SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. ACCORDINGLY, THE INDIVIDUALS MAY NEVER ACTUALLY RECEIVE THIS AMOUNT. THE AMOUNTS WERE NOT INCLUDED IN EACH INDIVIDUAL'S 2020 FORM W-2 AS TAXABLE WAGES: ROBERT C. GARRETT AND PATRICK YOUNG. THE DEFERRED COMPENSATION AMOUNTS REFLECTED IN COLUMN (C) FOR THE FOLLOWING INDIVIDUALS INCLUDE BENEFITS IN AN INTERNAL REVENUE CODE SECTION 457(F) PLAN (NON-QUALIFIED DEFERRED COMPENSATION PLAN). THESE AMOUNTS ARE SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. THESE INDIVIDUALS WILL NOT EARN THE RIGHT TO RECEIVE THE DEFERRED COMPENSATION AMOUNTS UNLESS AND UNTIL THEY PROVIDE SUBSTANTIAL FUTURE SERVICES TO THE ORGANIZATION. WHEN THE FUTURE SERVICES REQUIREMENT IS MET, THE AMOUNTS WILL BECOME VESTED, WILL BE TAXED, WILL BE INCLUDED ON THE W-2, AND WILL BE REPORTED AGAIN ON THIS SCHEDULE. JOSEPH E. STAMPE, MARK D. SPARTA, M.D., HELEN A. CUNNING, KENNETH N. SABLE, M.D., AUDREY C. MURPHY, ESQ., MSN, RN, PATRICK YOUNG, TODD WAY, DONNA SNIDER, AMIE THORNTON, AND MANUEL ALVAREZ, M.D.
Schedule J (Form 990) 2020

Additional Data


Software ID:  
Software Version: